Abstract. Galanin is a 29 amino acid peptide which has been found in intrapancreatic nerves. The effects of galanin, adrenergic and cholinergic blockade as well as somatostatin on the hormone release from the isolated perfused dog pancreas were studied. It was found that galanin dose-dependently inhibited insulin (P < 0.001) and somatostatin (P < 0.001) but not glucagon secretion at normal glucose levels. The lowest galanin concentration that caused a significant suppression of insulin and somatostatin secretion was 10\m=-\11and 10\m=-\10mol/l, respectively. Similar effects were evident during stimulation with 2.5 mmol/l arginine. Galanin (10\m=-\9 mol/l) caused a more pronounced inhibition of insulin and somatostatin secretion at high (10 mmol/l) and normal (5 mmol/l) than at low glucose (1.3 mmol/l). In contrast, suppression of the glucagon secretion was only seen at low glucose (1.3 mmol/l). Perfusion of 10\m=-\6mol/l of atropine, phentolamine and propranolol had no effect on the galanin-mediated (10\m=-\10 mol/l) inhibition of insulin and somatostatin secretion. Galanin (10\m=-\12\p=n-\10\ m=-\ 10 mol/l) and somatostatin (10\m=-\12\p=n-\10\ m=-\ 10 mol/l) were equipotent in inhibiting insulin secretion whereas only somatostatin exerted a suppression of the glucagon secretion at normal glucose. Thus, galanin exerts a differential effect on islet hormone secretion and may participate in the hormonal control of insulin, glucagon and somatostatin secretion.
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Galanin, a 29 amino acid peptide, was first isolated from porcine intestine (Tatemoto et al. 1983 ). This peptide, originally detected in nerves of the gut (Ekblad et al. 1985) and in the central nervous system (Rökaeus et al. 1984) , has now been de¬ monstrated in nerve fibres in association with the pancreatic islets (Dunning et al. 1986 ). Intraven¬ ous administration of galanin in conscious dogs produced hyperglycemia (Tatemoto et al. 1983; McDonald et al. 1985 ) and a concomitant decrease in plasma insulin (McDonald et al. 1985) . The In the dose-response studies, four different concen¬ trations of galanin (10"12, 10"», 10"10 and 10"9 mol/1) were administered in random order to each of six pancreata in the absence of arginine and to each of four pancreata in the presence of 2.5 mmol/1 arginine. In the study of the influence of the glucose level on galaninmediated hormone responses, the glucose concentra¬ tion (1.3, 5 and 10 mmol/1) was administered in random order to each of six pancreata. As for the study of the action of adrenergic and cholinergic blockers, the -, ß-adrenergic and cholinergic blockers were given during a 30-min period in random order to each of four pancreata. Galanin was added for a 10-min period when the blocker had been infused for 10 min. To compare the potency of galanin and somatostatin on the pancreatic A-and B-cell secretion, three concentrations (10"12, 10"n and 10"10 mol/1) of each of the two peptides were infused in random order to each of six pancreata.
Reagents
Substances used in this study were galanin ( 
Results
Effects ofgalanin at concentrations of 10~12, 10~n, 10-™and IO-9molli
The effects of galanin upon the release of gluca¬ gon, insulin and somatostatin were studied at a glucose concentration of 5.5 mmol/1 in six per¬ fusion experiments (Fig. 1 ). Galanin induced a dose-dependent inhibition of insulin (P < 0.001) and somatostatin (P < 0.001), whereas the gluca¬ gon secretion was unchanges. The lowest galanin concentrations that caused a significant suppres¬ sion of insulin and somatostatin were 10"11 mol/1 (P < 0.001) and 10"10 mol/1 (P < 0.01), respective¬ ly. The galanin-induced inhibition of insulin and somatostatin was immediately and reversible.
Effects ofgalanin (10'12to 10'9mol/l) in the presence of arginine (2.5 mmol/l) The effects of galanin (10~12 to 10~9 mol/1) on the A-, B-and D-cell secretion were also investigated in the presence of 2.5 mmol/1 arginine and a glu¬ cose concentration of 5.5 mmol/1 (Fig. 2) Comparison of the effects ofequimolar concentrations ofgalanin and somatostatin In each of six pancreas perfusions, the effect of 10-min infusions of equimolar galanin and soma¬ tostatin concentrations at 10"12, 10"11 and 10"10 mol/1 was compared in the presence of 5 mmol/1 glucose and 2.5 mmol/1 arginine. Fig. 4 demon¬ strates that galanin (IO-12, 10"11 and 10"10 mol/1) caused a dose-dependent inhibition of the insulin secretion (P < 0.01) by 16 ± 3, 22 ± 3 and 54 ±8%, respectively. Somatostatin at equimolar concentrations likewise subdued the insulin secre¬ tion in a dose-dependent manner (P<0.01) by^VWW-i Comparison of the effect of somatostatin at concentrations of 10'12(A), 10"n(B), 10"10(C) (upper panel) and galanin at concentrations of 10"12(A), 10"U(B) and 10"10(C) upon pancreatic glucagon and insulin release in the presence of 5 mmol/1 glucose and 2.5 mmol/1 arginine ( = 6, mean ± SEM). (McDonald et al. 1985 (McDonald et al. , 1986 Manabe et al. 1986 ) and in vitro in the perfused rat pancreas (Silvestre et al. 1987 (Larsson 1979; Ahrén et al. 1986 ) and are all able to modulate islet hormone secretion (Ahrén et al. 1986; Hermansen 1980d; Hermansen 1983 Hermansen , 1984 
